ADVANCED HEALTH LIMITED - Unaudited Condensed Consolidated Interim Financial Statements for the Six Months ended 31 December 2022

Unaudited Condensed Consolidated Interim Financial Statements for the Six Months ended 31 December 2022

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced”)
ISIN Code: ZAE000189049  JSE Code: AVL


UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2022


Financial performance overview
    Ø Profit after tax for the period decreased 50% to R0.4 million (2021 : R0.8 million).
    Ø Revenue (from continued operations) increased by 22% to R126.6 million (2021 : R103.9 million).
    Ø Cash generated from operations decreased by 5% to R76.8 million (2021 : R80.8 million).
    Ø Basic loss per share improved by 14% to 2.42 (2021 : 2.81 cents).
    Ø Headline loss per share improved by 86% to 0.06 cents (2021 : 0.92 cents).

No dividend were proposed for the current year.

Short-form announcement
The contents of the short-form announcement are the responsibility of the Board of Directors of Advanced Health
Limited. The information in the short-form announcement is a summary of the full announcement and accordingly
does not contain full or complete details. The full announcement is available for inspection at no charge, Monday to
Friday, during office hours at the company’s registered office, the office of the Designated Advisor and on the
Company’s website on http://www.advancedhealth.co.za/ from 31 March 2023. The full announcement is available
on SENS from 31 March 2023 at https://senspdf.jse.co.za/documents/2023/jse/isse/AVL/DEC2022AVL.pdf.

The information in this announcement has been extracted from the unaudited condensed consolidated interim
financial statements for the six months ended 31 December 2022 and the short-form announcement itself has not
been reviewed by the Company’s auditors. Any investment decisions by shareholders/investors should be based on
the full announcement released to the JSE and published on the Company’s website.


CORPORATE INFORMATION
Advanced Health Limited                                        Registered Address:
(Incorporated in the Republic of South Africa)                 Building 2, Walker Creek Office Park
Registration number: 2013/059246/06                            90 Florence Ribeiro Avenue
ISIN: ZAE000189049 JSE Code: AVL                               Muckleneuk
                                                               0002
                                                               Postnet Suite 668, Private Bag X1
                                                               The Willows, 0041

 Executive directors                                            Non-Executive Directors
 GJ van Emmenis (Chief Executive Officer)                       FA van Hoogstraten (Lead Independent)
 MC Resnik# (Managing Director - Australia)                     CA Grillenberger (Chairman)
 D Goss-Ross (Managing Director - South Africa)                 PJ Jaffe #
 S Chonco (Chief Financial Officer)                             CJPG van Zyl
                                                                Dr WT Mthembu
                                                                YJ Visser
                                                                   Dr KE Legodi

# Australian

Company Secretary:      M Janse van Rensburg
Auditors:               Mazars
Transfer Secretaries:   Link Market Services Proprietary Limited




Date of announcement: 3 April 2023
Designated Advisor
Grindrod Bank Limited

Date: 03-04-2023 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.